The Role of the Study Director in Nonclinical Studies
Pharmaceuticals, Chemicals, Medical Devices, and Pesticides
Invaluable guidance to manage nonclinical safety studies This book is a practical reference aiding Study Directors in the design, execution, and reporting of nonclinical studies. Managing the idiosyncrasies inherent in a nonclinical study represents a significant challenge that can only be learned from doing. The editors and authors provide such valuable lessons learned and case studies from their own extensive experience to guide readers. A single-source reference with a broad and holistic overview of nonclinical studies, this book: Provides a complete overview of nonclinical study organization, conduct, and reporting and describes the ro…
Mehr
CHF 99.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Mounho, Barbara (Mithrsg.) / Brock, William J. (Hrsg.)
- ISBN: 978-1-118-87408-0
- EAN: 9781118874080
- Produktnummer: 16380187
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2014
- Seitenangabe: 560 S.
- Plattform: EPUB
- Masse: 14'934 KB
Über den Autor
William J. Brock is the Principal of Brock Scientific Consulting, a Diplomate of ABT and a Fellow of ATS. Dr. Brock has over 30 years of experience with conducting nonclinical studies including genotoxicity, safety pharmacology, developmental and reproductive toxicology, carcinogenicity studies, etc. Barbara Mounho is a Biopharmaceutical Practice Leader at ToxStrategies, Inc., a Diplomate of ABT and a Fellow of ATS. Dr. Mounho has >15 years of experience in the nonclinical safety evaluation of therapeutic biological products. Lijie Fu is the Senior Director and Regulatory Advisor at SNBL. He is a Fellow of ATS with over 30 years' experience in toxicology, holding positions in non-clinical CROs in the US and China. Dr. Fu was retained by WHO as an expert to on Safety Evaluation and GLP Regulations.
1 weiteres Werk von Lijie (Mithrsg.) Fu:
Bewertungen
Anmelden